Literature DB >> 33387632

Effects of Low-Level Tragus Stimulation on Endothelial Function in Heart Failure With Reduced Ejection Fraction.

Tarun W Dasari1, Tamas Csipo2, Faris Amil3, Agnes Lipecz2, Gabor A Fulop2, Yunqiu Jiang4, Rajesh Samannan3, Sarah Johnston5, Yan D Zhao5, Federico Silva-Palacios3, Stavros Stavrakis6, Andriy Yabluchanskiy2, Sunny S Po6.   

Abstract

BACKGROUND: Autonomic dysregulation in heart failure with reduced ejection fraction plays a major role in endothelial dysfunction. Low-level tragus stimulation (LLTS) is a novel, noninvasive method of autonomic modulation. METHODS AND
RESULTS: We enrolled 50 patients with heart failure with reduced ejection fraction (left ventricular ejection fraction of ≤40%) in a randomized, double-blinded, crossover study. On day 1, patients underwent 60 minutes of LLTS with a transcutaneous stimulator (20 Hz, 200 μs pulse width) or sham (ear lobule) stimulation. Macrovascular function was assessed using flow-mediated dilatation in the brachial artery and cutaneous microcirculation with laser speckle contrast imaging in the hand and nail bed. On day 2, patients were crossed over to the other study arm and underwent sham or LLTS; vascular tests were repeated before and after stimulation. Compared with the sham, LLTS improved flow-mediated dilatation by increasing the percent change in the brachial artery diameter (from 5.0 to 7.5, LLTS on day 1, P = .02; and from 4.9 to 7.1, LLTS on day 2, P = .003), compared with no significant change in the sham group (from 4.6 to 4.7, P = .84 on day 1; and from 5.6 to 5.9 on day 2, P = .65). Cutaneous microcirculation in the hand showed no improvement and perfusion of the nail bed showed a trend toward improvement.
CONCLUSIONS: Our study demonstrated the beneficial effects of acute neuromodulation on macrovascular function. Larger studies to validate these findings and understand mechanistic links are warranted.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart failure with reduced ejection fraction; endothelial dysfunction; low-level tragus stimulation; noninvasive neuromodulation

Mesh:

Year:  2020        PMID: 33387632      PMCID: PMC9473302          DOI: 10.1016/j.cardfail.2020.12.017

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   6.592


  60 in total

Review 1.  Physiology and immunology of the cholinergic antiinflammatory pathway.

Authors:  Kevin J Tracey
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

Review 2.  Neural circuitry and immunity.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

3.  Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation.

Authors:  Stavros Stavrakis; Mary Beth Humphrey; Benjamin J Scherlag; Yanqing Hu; Warren M Jackman; Hiroshi Nakagawa; Deborah Lockwood; Ralph Lazzara; Sunny S Po
Journal:  J Am Coll Cardiol       Date:  2015-03-10       Impact factor: 24.094

4.  Reliability of peripheral arterial tonometry in patients with heart failure, diabetic nephropathy and arterial hypertension.

Authors:  Fabian Weisrock; Max Fritschka; Sebastian Beckmann; Simon Litmeier; Josephine Wagner; Elvis Tahirovic; Sara Radenovic; Christine Zelenak; Djawid Hashemi; Andreas Busjahn; Thomas Krahn; Burkert Pieske; Wilfried Dinh; Hans-Dirk Düngen
Journal:  Vasc Med       Date:  2017-05-30       Impact factor: 3.239

5.  Low-Level Vagus Nerve Stimulation Suppresses Post-Operative Atrial Fibrillation and Inflammation: A Randomized Study.

Authors:  Stavros Stavrakis; Mary Beth Humphrey; Benjamin Scherlag; Omer Iftikhar; Purvi Parwani; Mubasher Abbas; Adrian Filiberti; Christian Fleming; Yanqing Hu; Paul Garabelli; Arthur McUnu; Marvin Peyton; Sunny S Po
Journal:  JACC Clin Electrophysiol       Date:  2017-05-30

6.  TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation): A Randomized Clinical Trial.

Authors:  Stavros Stavrakis; Julie A Stoner; Mary Beth Humphrey; Lynsie Morris; Adrian Filiberti; Justin C Reynolds; Khaled Elkholey; Isma Javed; Nicholas Twidale; Pavel Riha; Subha Varahan; Benjamin J Scherlag; Warren M Jackman; Tarun W Dasari; Sunny S Po
Journal:  JACC Clin Electrophysiol       Date:  2020-01-29

Review 7.  Immune mechanisms in heart failure.

Authors:  Yingying Zhang; Johann Bauersachs; Harald F Langer
Journal:  Eur J Heart Fail       Date:  2017-09-11       Impact factor: 15.534

Review 8.  Microcirculation and Heart Failure.

Authors:  Davor Miličić; Nina Jakuš; Dora Fabijanović
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

9.  Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: a noninvasive approach to treat the initial phase of atrial fibrillation.

Authors:  Lilei Yu; Benjamin J Scherlag; Shaolong Li; Youqi Fan; John Dyer; Shailesh Male; Vandana Varma; Yong Sha; Stavros Stavrakis; Sunny S Po
Journal:  Heart Rhythm       Date:  2012-11-24       Impact factor: 6.343

10.  Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial.

Authors:  Faiez Zannad; Gaetano M De Ferrari; Anton E Tuinenburg; David Wright; Josep Brugada; Christian Butter; Helmut Klein; Craig Stolen; Scott Meyer; Kenneth M Stein; Agnes Ramuzat; Bernd Schubert; Doug Daum; Petr Neuzil; Cornelis Botman; Maria Angeles Castel; Antonio D'Onofrio; Scott D Solomon; Nicholas Wold; Stephen B Ruble
Journal:  Eur Heart J       Date:  2014-08-31       Impact factor: 29.983

View more
  1 in total

Review 1.  The role of age-associated autonomic dysfunction in inflammation and endothelial dysfunction.

Authors:  Yunqiu Jiang; Andriy Yabluchanskiy; Jielin Deng; Faris A Amil; Sunny S Po; Tarun W Dasari
Journal:  Geroscience       Date:  2022-06-30       Impact factor: 7.581

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.